Lilly supports global Dementia Discovery Fund
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Lilly supports global Dementia Discovery Fund
October 22, 2015 6:21 AM EDT
Eli Lilly & Co. (NYSE: LLY) and AstraZeneca (NYSE: AZN) announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.
Under the terms of the expanded agreement, Lilly and AstraZeneca will evaluate the safety and efficacy of a range of additional combinations across the companies' complementary portfolios. Lilly will lead the execution of the studies, while both companies will contribute resources. Additional... More
October 21, 2015 6:34 AM EDT
Eli Lilly & Co. (NYSE: LLY) announced it will be a key collaborator in the $100 million Dementia Discovery Fund (DDF), which aims to accelerate the discovery and development of new treatments for dementia. This first-ever global dementia research fund recently launched after securing backing from investors including Lilly, the UK Government's Department of Health, Alzheimer's Research UK and a number of other global pharmaceutical companies will invest in research into treatments for the condition.
"Lilly is delighted to be a partner in the Dementia Discovery Fund. Alzheimer's disease is one of... More
